The Food and Drug Administration is expected to decide Tuesday whether or not to approve "the little pink pill," the world's first drug designed to boost a woman's sexual desire.

Flibanserin, made by Sprout Pharmaceuticals, has been already been rejected twice by the FDA, which said the pill's benefits do not outweigh its side effects, which include dizziness and fainting.

Advocates for flibanserin - known publicly as "female Viagra" - note that one in 10 women suffer from low libido.

Kennedy appeared on "Shepard Smith Reporting" today and said that she believes there's nothing wrong with this drug, and the FDA often makes arbitrary decisions.

"There are women out there who are underserved through pharmaceuticals. And perhaps they need a bit of a boost," Kennedy said. "And if the money's there, if the market's there, then, by goodness, service them."

Watch the "Shepard Smith Reporting" clip above.


Alabama Sorority Deletes Viral Recruitment Video After Backlash

YouTube Star Shows Just How Easy It Is to Lure Teens Using Social Media

WATCH: Frustrated Mom Calls on Jazz Band to Wake Her Daughter Up for School